Original Article

Utilization of Healthcare Resources by HIV-Positive Children in the United States: A National Perspective

Authors: Brook T. Alemu, PhD, MPH, David W. Brock, PhD, Sara N. Abate, BS, Brian C. Martin, PhD


Objective: We characterized and estimated the cost of inpatient hospital utilization by US pediatric patients who tested positive for the human immunodeficiency virus (HIV).

Methods: The 2012 Kids’ Inpatient Database was analyzed to provide a descriptive assessment of national inpatient hospital utilization. We analyzed a stratified probability sampling of 3.2 million pediatric hospital discharges weighted to 6.7 million national discharges. Descriptive statistics for hospital and patient characteristics were identified and binary variables were analyzed using the Student t test. The Kids’ Inpatient Database is the largest available all-payer pediatric (20 years old and younger) inpatient care database in the United States, yielding national estimates of hospital inpatient stays. Children aged 17 years and younger were included in the study and conditions related to pregnancy and delivery.

Results: We estimated that 1344 pediatric discharges were associated with an HIV diagnosis, totaling 10,704 inpatient days at a cost of $91 million. Among pediatric patients with HIV, 55% were African American, 20% were white, 15% were Asian/Pacific Islander, 8% were other races (including Hispanics and Native Americans), and 51% were female. Children who were HIV positive were more likely to have longer mean hospital stays, have higher mean hospital charges, be of a higher median age (8 years and older), have Medicaid insurance, come from lower-income families, be treated in urban teaching hospitals, and be more likely to die during hospitalization (P < 0.01 for all). Among non-HIV-related pediatric discharges, 20% occurred in households with a mean annual income >$63,000 compared with only 12% for children who were HIV positive. During hospitalization, at least one procedure was performed in 56.6% of children with HIV compared with 45.65% of hospitalized children without HIV. The most frequently observed diagnoses associated with children infected with HIV were gastrointestinal disorders, mental disorders, and bacterial infections and sepsis.

Conclusions: The results suggest that pediatric patients who were HIV positive were significantly older, from lower-income areas, and members of minority groups. They underwent more procedures during hospitalization, incurred more than twice the total cost, stayed in the hospital twice as long, and had statistically higher in-hospital mortality than children who were HIV negative. As we continue to explore effective and judicious treatment options for patients who are HIV positive, our national estimates of resource utilization can be used to conduct a more detailed examination of current medical practices and specific patterns of diagnoses associated with HIV infection in the US pediatric population.
Posted in: Infectious Disease90 Acquired Immunodeficiency Syndrome (AIDS) And Human Immunodeficiency Virus (HIV) Infection12

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. World Health Organization. Health in 2015: from MDGs to SDGs. Infectious diseases. HIV/AIDS. http://www.who.int/gho/publications/mdgs-sdgs/MDGs-SDGs2015_chapter5_hiv_.pdf. Published December 2015. Accessed November 14, 2018.
2. Centers for Disease Control and Prevention. CDC Fact Sheet. Trends in U.S. HIV diagnoses, 2005-2014. https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/hiv-data-trends-fact-sheet-508.pdf. Published February 2016. Accessed December 10, 2018.
3. Dieffenbach CW, Fauci AS. Thirty years of HIV and AIDS: future challenges and opportunities. Ann Intern Med 2011;154:766-771.
4. UNAIDS. UNAIDS report on the global AIDS epidemic. https://www.unaids.org/en/resources/documents/2012/20121120_UNAIDS_Global_Report_2012. Published November 20, 2012. Accessed November 14, 2018.
5. Palmisano L, Vella S. A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanita 2011;47:44-48.
6. Michaels SH, Clark R, Kissinger P. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;339:405-406.
7. Palella FJ, Jr Chmiel JS, Moorman AC, et al. Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients. AIDS 2002;16:1617-1626.
8. Buchacz K, Baker RK, Moorman AC, et al. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005. AIDS 2008;22:1345-1354.
9. Mocroft A, Monforte Ad, Kirk O, et al. Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study. HIV Med 2004;5:437-447.
10. Fontas E, van Leth F, Sabin CA, et al. Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis 2004;189:1056-1074.
11. Healthcare Cost and Utilization Project. KID overview. https://www.hcup-us.ahrq.gov/kidoverview.jsp. Accessed December 7, 2019.
12. Centers for Disease Control and Prevention. (2004;). International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). https://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed December 7, 2019.
13. Healthcare Cost and Utilization Project. HCUP summary statistics report: KID 2012 core file. https://www.hcup-us.ahrq.gov/db/nation/kid/kidsummarystats.jsp#2012. Accessed November 14, 2018.
14. Centers for Disease Control and Prevention. HIV surveillance supplemental report. Estimated HIV incidence and prevalence in the United States, 2010-2015. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-23-1.pdf. Accessed December 7, 2019.
15. Centers for Disease Control and Prevention. HIV/AIDS surveillance report: cases of HIV infection and AIDS in the United States, 2003, Vol. 15. https://www.cdc.gov/hiv/pdf/statistics_2003_HIV_Surveillance_Report_vol_15.pdf. Accessed December 7, 2019.
16. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2017: STDs in racial and ethnic minorities. https://www.cdc.gov/std/stats17/minorities.htm. Accessed December 7, 2019.
17. Brogly S, Williams P, Seage GR 3rd, et al. Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. JAMA 2005;293:2213-2220.
18. Cohen S, ter Stege JA, Weijsenfeld AM, et al. Health-related quality of life in perinatally HIV-infected children in the Netherlands. AIDS Care 2015;27:1279-1288.
19. Malee KM, Tassiopoulos K, Huo Y, et al. Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure. AIDS Care 2011;23:1533-1544.
20. Murphy DA, Wilson CM, Durako SJ, et al. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care 2001;13:27-40.
21. Williams PL, Storm D, Montepiedra G, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics 2006;118:e1745-e1757.
22. Centers for Disease Control and Prevention. HIV Surveillance Report, Vol 25: diagnoses of HIV infection in the United States and dependent areas, 2013. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2013-vol-25.pdf. Published February 2015. Accessed May 31, 2019.